These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8161111)

  • 1. [Kawasaki disease].
    Lebranchu Y
    Ann Dermatol Venereol; 1993; 120(9):587-8. PubMed ID: 8161111
    [No Abstract]   [Full Text] [Related]  

  • 2. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N; Teramura K; Tanaka T
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract]   [Full Text] [Related]  

  • 3. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 5. Inflammation at a previous inoculation site: an unusual presentation of Kawasaki disease.
    Weinstein M
    CMAJ; 2006 Feb; 174(4):459-60. PubMed ID: 16477055
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient characteristics and intravenous immunoglobulin product may affect eosinophils in Kawasaki disease.
    Kuo HC; Wang CL; Wang L; Yu HR; Yang KD
    Pediatr Allergy Immunol; 2008 Mar; 19(2):184-5. PubMed ID: 18257906
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.
    Kobayashi T; Kimura H; Okada Y; Inoue Y; Kobayashi T; Shinohara M; Morikawa A
    Clin Exp Immunol; 2007 Apr; 148(1):112-8. PubMed ID: 17286760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Kawasaki disease.
    Glode MP; Burns JC
    Pediatr Infect Dis J; 1992 Mar; 11(3):249-50. PubMed ID: 1565549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kawasaki disease--two case reports].
    Mroczkowska-Juchniewicz A; Moszyńska B; Pawłowska-Kamieniak A; Szczepanowska A; Papierkowski A
    Pol Merkur Lekarski; 1997 Jul; 3(13):20-1. PubMed ID: 9432293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kawasaki syndrome in adults: treatment with polyvalent intravenous immunoglobulins].
    Pavese P; Brion JP; Meusnier T; Stahl JP
    Ann Med Interne (Paris); 1997; 148(3):287-8. PubMed ID: 9255342
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of efficacy of intravenous immunoglobulin in Kawasaki disease.
    Kaneka K; Savage CO; Pottinger BE; Shah V; Pearson JD; Dillon MJ
    Pediatr Infect Dis J; 1994 Nov; 13(11):1022-3. PubMed ID: 7845731
    [No Abstract]   [Full Text] [Related]  

  • 13. Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage.
    Singh S; Kumar L
    Indian Pediatr; 1996 Aug; 33(8):689-92. PubMed ID: 8979554
    [No Abstract]   [Full Text] [Related]  

  • 14. IVIG, aspirin, and Kawasaki disease.
    Morgan GJ; MacLeod C; Jenkins J; Stewart C; Craig B
    J Pediatr; 2003 Aug; 143(2):280-1; author reply 281. PubMed ID: 12970651
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons from Kawasaki disease: all brands of IVIG are not equal.
    Stiehm ER
    J Pediatr; 2006 Jan; 148(1):6-8. PubMed ID: 16423589
    [No Abstract]   [Full Text] [Related]  

  • 16. Kawasaki disease in Calcutta.
    Paul DK; Gupta A; Lahiri M
    Indian Pediatr; 2000 Nov; 37(11):1264-5. PubMed ID: 11086312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].
    Zhang Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):318-21. PubMed ID: 19374823
    [No Abstract]   [Full Text] [Related]  

  • 18. The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.
    Leung DY
    Clin Rev Allergy; 1992; 10(1-2):93-104. PubMed ID: 1606527
    [No Abstract]   [Full Text] [Related]  

  • 19. [New aspects of therapy in Kawasaki disease].
    Keren G; Ballin A
    Harefuah; 1994 Jun; 126(11):667-71. PubMed ID: 7927003
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L; Drissa MA; Drissa H
    Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.